About Dako - An Agilent Technologies Company
When a person is confronted with a possible cancer diagnosis, a biopsy is performed and tissue is taken out. The tissue is tested in a pathology lab and a report is generated. The report confirms or rules out a cancer diagnosis and determines the ‘stages’ or to what extent the cancer has spread. Treatment options are found by information on the size, shape and appearance of the tissue under a microscope. Dako provides the antibodies, reagents and instruments enabling physicians to select the most appropriate form of treatment, the first time.
We are helping doctors help their patients.
Mar 05, 2014
Dako White Paper Outlines High-Quality Staining Enabled by Its New Immunohistochemical Staining Principle
Mar 04, 2014
Mar 03, 2014
Feb 28, 2014